Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Effect of Home-base Exercise Program With a Conical Positive Expiratory Pressure Device on Physical Performance and Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease
The aim of this study to investigate the efficacy of a home-base exercise program with a new conical PEP device on physical performance and health related quality of life in COPD patients.
The key pathophysiology of COPD is expiratory flow limit and hyperinflation that is a major
factor related exertional dyspnea and exercise limitation. When expiratory minute volume( V
̇E) raise up while exercise, respiratory response by increase respiratory rate (RR) and
tidal volume (VT), force exhalation occur lead to develop premature airway closer. These
generate dynamic air tapping breath by breath and result in dynamic hyperinflation (DH). The
DH limits VT expansion, increase respiratory muscle load, and it is a major cause related
dyspnea and exercise termination. Furthermore, Pre-inflammatory products from the COPD lung
contribute to another system, and provoke systemic inflammation lead to nutritional
abnormalities, weight loss, skeletal muscle dysfunction, osteo-skeletal effect,
cardiovascular effect and psychological effect. All of these affect the exercise tolerance
and gradually affect physical activity and health-related quality of life (HRQL) as well.
COPD GOLD guideline states that goal for treatments of stable COPD comprise of relive
symptoms, improve exercise tolerance, improve health status, prevent disease progression and
reduce mortality. Several evidences have suggested an effect of pulmonary rehabilitation
(PR) in patient with stable COPD and following acute exacerbation. Strong evidences reported
that the PR program could improve exercise tolerance, reduce dyspnea, decrease fatigue and
improve health-related quality of life.
The core stone of PR is an exercise program. Several types of exercise were published such
as endurance exercise, interval exercise, strengthening exercise, respiratory muscle
strengthening and breathing exercise. Most COPD patient stop exercise causes from dyspnea
that related DH development during exercise. Previous studies reported various strategies to
reduce DH development during exercise for extending exercise time or increase exercise
capacity in immediate effect such as bronchodilators , hyperoxic breathing, heliox
breathing, positive pressure therapy by non-invasive positive pressure ventilation (NIPPV),
by pursed lip breathing (PLB) and by positive expiratory pressure (PEP) device.
The PEP therapy have been conventionally using for reduce premature airway closer by moving
equal pressure point from distal to proximal, improve gas exchange and improve secretion
clearance. In the past decade, the knowledge of dynamic hyperinflation in COPD patient has
rapidly glowed up. The PEP device and PLB have used to reduce DH development during exercise
that reported in only 5 studies. They expected that delay DH development, it may delay
exertional dyspnea, and may result in improve exercise capacity.
Three studies reported DH parameter at pre and post exercise. Results indicated that using
the PEP device can reduce DH when measuring immediate post exercise. However, effects of
positive pressure therapy (PEP device and PLB) on exercise capacity were also inconclusive.
But three studies showed positive effect of PEP therapy on exercise capacity.
Training effect of PEP therapy on physical performance and quality of life was present in
two studies. The first study showed the benefit of breathing retraining (including PLB, and
other breathing techniques) that were integrated to all daily activities and exercise
program, superior than control group in peak oxygen consumption after 7th week of exercise
program. The second study applied PLB to reduce DH during exercise program. They found that
after ten sessions (within 3 to 4 weeks) of program, both PLB and control groups
significantly improve 6 minute walk distance and quality of life, but non-significant effect
between groups. To date there was only two studies of PEP therapy applying to exercise
program, and results were not conclusive.
In spite of the PLB was wildly used, but positive pressure from this technique was reported
about 5 cm H2O, it is lower boundary of therapeutic pressure range (5 to 20 cm H2O), this
may result in a non-success of DH reduction. Consequently, The PEP device may be a
convenient alternative way to generate positive pressure within therapeutic range for
reduces DH during exercise or daily activities living. This may increase patient's physical
performance and quality of life greater that exercise alone.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|